Cerecor Inc. Uncategorized Contracts & Agreements
19 Contracts & Agreements
- Avalo Therapeutics, Inc (Filed With SEC on August 14, 2024)
- Avalo Therapeutics, Inc. Fo (Filed With SEC on August 14, 2024)
- Description of Registered Securities (Filed With SEC on March 2, 2022)
- Letter Agreement, dated February (Filed With SEC on February 18, 2022)
- Letter Agreement, dated February 18, 2022, by and between Avalo Therapeutics, Inc. and Garry Neil (Filed With SEC on February 18, 2022)
- Amendment No (Filed With SEC on August 2, 2021)
- Controlled Equity Offering (Filed With SEC on July 2, 2021)
- Offer Letter, dated February 19, 2020, from Cerecor Inc. to H. Jeffrey Wilkins, M.D (Filed With SEC on March 8, 2021)
- Description of Registered Securities (Filed With SEC on March 8, 2021)
- Amendment No. 6 to Sponsored Research Agreement, dated as of (Filed With SEC on November 20, 2020)
- Letter Agreement, dated April 23, 2020, by and between Cerecor Inc. and Christopher Sullivan (Filed With SEC on April 27, 2020)
- Description of Registered Securities (Filed With SEC on March 11, 2020)
- Backstop Agreement, dated December 5, 2019, by and between Cerecor Inc. and Armistice Capital Master Fund Ltd (Filed With SEC on December 5, 2019)
- Form of Contingent Value Rights Agreement by and between Cerecor Inc. and Rights Agent (Filed With SEC on December 5, 2019)
- [Cerecor, Inc. Letterhead] (Filed With SEC on November 8, 2016)
- Form of UPO (Filed With SEC on October 20, 2015)
- SPECIMEN UNIT CERTIFICATE (Filed With SEC on October 13, 2015)
- CERECOR INC. (Filed With SEC on June 12, 2015)
- Cerecor Inc. 75 Rockefeller Plaza, 29thFloor New York, NY 10019 (Filed With SEC on June 12, 2015)
